Targeting Glycosylation: A New Road for Cancer Drug Discovery
Top Cited Papers
Open Access
- 4 May 2020
- journal article
- review article
- Published by Elsevier BV in Trends in Cancer
- Vol. 6 (9), 757-766
- https://doi.org/10.1016/j.trecan.2020.04.002
Abstract
No abstract availableFunding Information
- Fundo Europeu de Desenvolvimento Regional
- Norte Portugal Regional Programme
- Portuguese funds through Fundação para a Ciência e a Tecnologia (FCT)/Ministério da Ciência, Tecnologia e Inovação
This publication has 59 references indexed in Scilit:
- High‐Throughput Screening for Inhibitors of Sialyl‐ and FucosyltransferasesAngewandte Chemie-International Edition, 2011
- Fluorescence polarization assays in small molecule screeningExpert Opinion on Drug Discovery, 2010
- Monoclonal antibodies: versatile platforms for cancer immunotherapyNature Reviews Immunology, 2010
- Scintillation Proximity Assays in High-Throughput ScreeningASSAY and Drug Development Technologies, 2008
- A Strategy to Discover Inhibitors of O-Linked GlycosylationJournal of the American Chemical Society, 2007
- Drug Resistance and the Solid Tumor MicroenvironmentJNCI Journal of the National Cancer Institute, 2007
- Increased susceptibility to colitis and colorectal tumors in mice lacking core 3–derived O-glycansThe Journal of Experimental Medicine, 2007
- Comparing antibody and small-molecule therapies for cancerNature Reviews Cancer, 2006
- Discovery of O-GlcNAc Transferase InhibitorsJournal of the American Chemical Society, 2005
- High-throughput identification of fucosyltransferase inhibitors using carbohydrate microarraysBioorganic & Medicinal Chemistry Letters, 2004